AI News NQ Analysis

Triad Japan Co., Ltd. to Establish New Pharmaceutical Development Division Office in Nihombashi-Kayabacho, Tokyo, in Line with Business Expansion

NQ Score 44/100
N1 Content Completeness 5

AI Summary (NQ-processed)

Triad Japan Co., Ltd. (Tokyo Office: Shibuya-ku, Tokyo; Representative Director: Mihoko Goto; hereinafter “Triad Japan”) announces the establishment of a new Pharmaceutical Development Division office in Nihombashi-Kayabacho, Tokyo, in August 2026, in response to business expansion and organizational strengthening. The move aims to enhance collaboration with pharmaceutical and healthcare institutions and strengthen clinical trial support infrastructure.

AI Analysis

Frequently Asked Questions

Q: What is the nearest station to the new office?
A: It's a 1-minute walk from Kayabacho Station on the Tokyo Metro Tozai and Hibiya Lines.
Q: Where is Triad Japan's headquarters located?
A: The headquarters is located at 3-14-20 Sagamidai, Minami-ku, Sagamihara, Kanagawa Prefecture.
Q: What kind of operations will be conducted at the new office?
A: It will serve as the Pharmaceutical Development Division, handling planning, execution, and management of clinical trial support.